annb0t
Top 20
For the quarter ended December 2023, ResMed (RMD) reported revenue of $1.16 billion, up 12.5% over the same period last year. EPS came in at $1.88, compared to $1.66 in the year-ago quarter.
The reported revenue represents a surprise of +0.46% over the Zacks Consensus Estimate of $1.16 billion. With the consensus EPS estimate being $1.81, the EPS surprise was +3.87%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall...
>>> Read more: ResMed (RMD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The reported revenue represents a surprise of +0.46% over the Zacks Consensus Estimate of $1.16 billion. With the consensus EPS estimate being $1.81, the EPS surprise was +3.87%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall...
>>> Read more: ResMed (RMD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
